Skip to main content

Advertisement

SpringerLink
Log in

Letter to the Editor: Very low-dose antithymocyte globulin (thymoglobulin) is effective for steroid-refractory acute graft-versus-host disease involving the skin or gut after allogeneic hematopoietic stem cell transplantation

  • Letter to the Editor
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Khoury H, Kashyap A, Adkins DR, Brown RA, Miller G, Vij R, et al. Treatment of steroid resistant acute graft-versus-host disease with anti-thymocyte globulin. Bone Marrow Transplant. 2001;27:1059–64.

    Article  CAS  Google Scholar 

  2. Murata M, Ikegame K, Morishita Y, Ogawa H, Kaida K, Nakamae H, et al. Low-dose thymoglobulin as second-line treatment for steroid-resistant acute GvHD: an analysis of the JSHCT. Bone Marrow Transplant. 2017;52:252–7.

    Article  CAS  Google Scholar 

  3. Nishimoto M, Nakamae H, Koh H, Nakamae M, Hirose A, Hayashi Y, et al. Response-guided therapy for steroid-refractory acute GVHD starting with very-low-dose antithymocyte globulin. Exp Hematol. 2015;43:177–9.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan

    Yuta Yamada, Tatsuya Konishi, Akihito Nagata, Takashi Toya, Yuho Najima, Takeshi Kobayashi, Kazuteru Ohashi & Noriko Doki

Authors
  1. Yuta Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tatsuya Konishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Akihito Nagata
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takashi Toya
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuho Najima
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Takeshi Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kazuteru Ohashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Noriko Doki
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

YY, TK, AN, TT, YN, TK, and ND contributed to the clinical care of the patient. KO supervised the project. YY and ND wrote the manuscript.

Corresponding author

Correspondence to Noriko Doki.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Ethical approval

Our institutional committee on research ethics approved the study, which was performed in compliance with the Declaration of Helsinki.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamada, Y., Konishi, T., Nagata, A. et al. Letter to the Editor: Very low-dose antithymocyte globulin (thymoglobulin) is effective for steroid-refractory acute graft-versus-host disease involving the skin or gut after allogeneic hematopoietic stem cell transplantation. Int J Hematol 115, 449–451 (2022). https://doi.org/10.1007/s12185-021-03234-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-021-03234-3

Keywords

Search

Navigation